{"id":"https://genegraph.clinicalgenome.org/r/22479881-0f2a-4d44-a939-4475d1d7c03cv1.0","type":"EvidenceStrengthAssertion","dc:description":"SLC25A46 was first reported in 2015 associated to an autosomal recessive axonal sensorimotor polyneuropathy with a Charcot-Marie-Tooth phenotype combined with optic atrophy (HMSN6) and, to a variable extent, to further central nervous system manifestations including cerebellar ataxia and spasticity (Abrams et al., PMID: 26168012). The clinical pattern is heterogeneous. In contrast to optic atrophy, single cases have been reported without a detectable neuropathy at the date of examination (PMIDs: 32259769, 28369803). The age at onset varies from congenital to childhood manifestations. 12 missense, 2 nonsense, 2 frameshift, and 2 splice variants have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 20 probands in 11 separate publications (PMIDs: 26168012, 30178502, 27430653, 27543974, 28653766, 28558379, 28637197, 26951855, 27390132, 32259769, 28369803). This gene-disease relationship is supported by expression studies and animal models. SLC25A46 is a modified carrier protein localized in the outer mitochondrial membrane. It plays a major role in mitochondrial dynamics (fission) (Abrams et al., PMID: 26168012). In HeLa cells, SLC25A46 knockdown resulted in mitochondrial elongation, which was found to be associated to fission defects (electron microscopy, Abrams et al., PMID: 26168012). In a zebrafish model, motor neurons had significantly shorter axons tracts (Abrams et al., PMID: 26168012). In sciatic nerve of Slc25a46-/- mice, mitochondria clumped together with disorganized or abolished cristae (Li et al., PMID: 28934388), whereas AAV–Slc25a46 rescued the abnormal distribution of mitochondria in mice sciatic nerves accordingly improving nerve conduction studies as well (Li Yang et al., PMID:31943007). In summary, SLC25A46 is definitively associated with an autosomal recessive syndrome including axonal Charcot-Marie-Tooth disease, optic atrophy, and variable central nervous system manifestations. This has been repeatedly demonstrated in both research and clinical diagnostic settings, and has been upheld over time.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/22479881-0f2a-4d44-a939-4475d1d7c03c","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9852fb40-0df1-4668-ba57-38a4971cb244","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9852fb40-0df1-4668-ba57-38a4971cb244_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2020-09-16T19:23:27.427Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/9852fb40-0df1-4668-ba57-38a4971cb244_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2020-05-26T16:00:00.000Z","role":"Approver"}],"curationReasonDescription":"Evidence has been replicated over time.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9852fb40-0df1-4668-ba57-38a4971cb244_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9852fb40-0df1-4668-ba57-38a4971cb244_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cbd6853-1da1-4e15-9215-2652e8fee73e","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be8e512f-b701-4491-99ff-44d709e10eff","type":"Finding","dc:description":"A Slc25a46 knock-out mouse model resulted in enhanced hind limb clasping reflex and muscle atrophy. In sciatic nerves, it has been shown abnormal mitochondrial morphology and decrease of CVs, CMAP amplitudes, myelin thickness and axon diameter.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28934388","rdfs:label":"Slc25a46 knock-out mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b09a601e-f802-401c-a68a-d1f891575d60","type":"EvidenceLine","dc:description":"Morpholino model and not stable knockdown.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/459f2823-04b1-4680-bb4e-3f0b2f20b2a2","type":"Finding","dc:description":"Embryos had fewer retinal ganglion cell axons that reached the tectum by 72 hpf. Motor neurons had significantly shorter axons tracts. Axonal blebbing and degeneration was observed at the morphant motor neuron terminals","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","rdfs:label":"Zebrafish SLC25A46 knockdown","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/eb432c0f-9eca-48f5-9494-c42f2f8c5000","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea719668-57ea-4148-89cc-b90c3ee64c3e","type":"Finding","dc:description":"Pan-neuron-specific dSLC25A46a knockdown resulted in impaired motility in both larvae and adults. At neuromuscular junctions, it was found an aberrant morphology, mitochondrial hyperfusion, together with the accumulation of reactive oxygen species and reductions in ATP.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32140609","rdfs:label":"Drosophila dSLC25A46a knockdown","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bfe01267-d735-4cfd-b546-e59740bc1a20","type":"EvidenceLine","dc:description":"Patients variants were not tested.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d98af6cd-2a58-4e20-b37a-768e4cd89ad8","type":"Finding","dc:description":"AAV–Slc25a46 rescued demyelination and abnormal distribution of mitochondria in sciatic nerves. It also improved nerve conduction velocity and amplitude","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31943007","rdfs:label":"AAV-SLC25a46 treatment","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/9852fb40-0df1-4668-ba57-38a4971cb244_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8561bb77-393e-4177-ba3e-5e47f68910e3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ac7862c-cdc1-4a26-8a02-cbad1135012e","type":"Finding","dc:description":"MFN2 plays a major role in mitochondrial fusion. MFN2 deficient cells have abnormal fragmented mitochondria.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","rdfs:label":"Mitochondrial fusion/fission dynamics","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5},{"id":"https://genegraph.clinicalgenome.org/r/9852fb40-0df1-4668-ba57-38a4971cb244_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ed73dd86-4e08-4688-9200-b30efb864b60_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Functional evidence is given by Wan et al., 2016, PMID: 27543974, Figure 2F and by Abrams et al., 2018, PMID: 30178502, Figure 3A, B","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/776d36d5-3386-4873-bfc6-a2727ab068e0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","rdfs:label":"PLII-5","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Optic atrophy, Progressive visual loss, Muscle weakness, Hyperreflexia, Ataxia, Cerebellar atroph","phenotypes":["obo:HP_0001272","obo:HP_0001324","obo:HP_0000529","obo:HP_0001347","obo:HP_0001251","obo:HP_0000648"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ed73dd86-4e08-4688-9200-b30efb864b60_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","allele":{"id":"https://genegraph.clinicalgenome.org/r/6f846fc4-1c37-411d-ad54-3a45af6509ca","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138773.4(SLC25A46):c.1005A>T (p.Glu335Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16042257"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3aef4ea3-4c21-4f61-8835-fd53863ebbc4_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e4fb890-1e12-471f-a3df-19a4d8d24be4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28653766","rdfs:label":"II-3","ageType":"AgeAtDeath","ageUnit":"Days","ageValue":1,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","previousTesting":true,"previousTestingDescription":"DMPK (repeat expansion), SMN1 (deletion analysis)","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3aef4ea3-4c21-4f61-8835-fd53863ebbc4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28653766","allele":[{"id":"https://genegraph.clinicalgenome.org/r/1387e211-bd0b-48c3-a804-0afbae7502dd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138773.4(SLC25A46):c.736A>T (p.Arg246Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA360696095"}},{"id":"https://genegraph.clinicalgenome.org/r/1d671508-9730-4954-b965-c75a2c9ab1ec","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NR_138151.2(SLC25A46):n.575+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA360694568"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/612790aa-ded6-4d47-851b-a040cef9f9e1_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Experimental data do not only show a reduced protein expression, but also mitochondrial elongation in patient-derived fibroblasts (functional evidence is given for this variant in the same paper (figure 4) and by Abrams et al., 2018, PMID: 30178502, Figure 3A, B). With this strong evidence, we decided to elevate the score from default 1 to 1.5 Points.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/314e932c-21df-4672-a958-ac35aaed373f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","rdfs:label":"ITII-3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Optic atrophy, Progressive visual loss, Distal sensory impairment, Muscle weakness, Pes cavus, Steppage gait, Gait disturbance, Hyporeflexia, Hyperreflexia, Ataxia, Nystagmus, Cerebellar atrophy","phenotypes":["obo:HP_0001324","obo:HP_0002936","obo:HP_0000648","obo:HP_0001251","obo:HP_0003376","obo:HP_0001288","obo:HP_0001265","obo:HP_0001761","obo:HP_0000529","obo:HP_0001347","obo:HP_0001272","obo:HP_0000639"],"previousTesting":true,"previousTestingDescription":"mtDNA, OPA1","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/612790aa-ded6-4d47-851b-a040cef9f9e1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","allele":{"id":"https://genegraph.clinicalgenome.org/r/054d1568-5a7b-41c4-85a4-9d340b479f12","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138773.4(SLC25A46):c.1018C>T (p.Arg340Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3364801"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7f8bbb49-d877-4592-8401-57b9dae56db4_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/858f6bc1-060d-4b71-a42c-b44be68f8c2f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28653766","rdfs:label":"VI.5","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Respiratory failure, Muscular hypotonia, Cerebellar atrophy, Abnormal cerebellum morphology, Muscle weakness","phenotypes":["obo:HP_0001324","obo:HP_0001317","obo:HP_0002878","obo:HP_0001252","obo:HP_0001272"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7f8bbb49-d877-4592-8401-57b9dae56db4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28653766","allele":{"id":"https://genegraph.clinicalgenome.org/r/f3e42811-cdec-4d41-8e52-144fb1e46294","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NR_138151.2(SLC25A46):n.155C>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA360693027"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c753e686-4486-458a-b4f1-109aff452c4c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Functional data in this same paper, expression level normal, however, protein interaction disturbed.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f01e4572-e618-4d4e-bfda-fec9256ed648","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30178502","rdfs:label":"II-2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":8,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Optic atrophy, Progressive visual loss, Muscle weakness, Hyporeflexia, Ataxia","phenotypes":["obo:HP_0001251","obo:HP_0000648","obo:HP_0001265","obo:HP_0000529","obo:HP_0001324"],"previousTesting":true,"previousTestingDescription":"SNP microarray","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c753e686-4486-458a-b4f1-109aff452c4c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30178502","allele":{"id":"https://genegraph.clinicalgenome.org/r/d416bdf1-e464-413c-b2d8-7c87480ef59d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138773.4(SLC25A46):c.770G>A (p.Arg257Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/559386"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e2e6743f-89fa-4a71-92ce-f1229570fc42_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Functional evidence provided by Abrams et al., 2018, PMID: 30178502, Figure 3A, B.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/068e5c6b-f11e-4a4f-81b2-ed17ca769ae6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27430653","rdfs:label":"II-3","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e2e6743f-89fa-4a71-92ce-f1229570fc42_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27430653","allele":{"id":"https://genegraph.clinicalgenome.org/r/62c9e640-1c55-4958-a6ef-5695d6671ebd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138773.4(SLC25A46):c.413T>G (p.Leu138Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16043963"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/125717cf-2e12-40b1-b6a7-1d57a0150b3e_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/098a1f18-7d22-4622-8562-fa5bba3ffa3e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","rdfs:label":"USII-3 372241","ageType":"AgeAtOnset","ageUnit":"Months","detectionMethod":"","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Muscular hypotonia, Generalized hypotonia, Narrow forehead, Flexion contracture, Bulbous nose, Anteverted nares, Tented upper lip vermilion, Tapered finger, Narrow palate, Respiratory failure, Inverted nipples, Optic atrophy","phenotypes":["obo:HP_0001252","obo:HP_0001371","obo:HP_0002878","obo:HP_0000648","obo:HP_0000341","obo:HP_0000189","obo:HP_0010804","obo:HP_0000463","obo:HP_0003186","obo:HP_0001182","obo:HP_0000414","obo:HP_0001290"],"previousTesting":true,"previousTestingDescription":"TSEN54, POLG1, POLG2, LAMA, microArray","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/125717cf-2e12-40b1-b6a7-1d57a0150b3e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","allele":[{"id":"https://genegraph.clinicalgenome.org/r/68779bb6-2bf1-48e6-a55b-efc7dc3bdf60","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138773.4(SLC25A46):c.882_885dup (p.Asn296LeufsTer3)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16042258"}},{"id":"https://genegraph.clinicalgenome.org/r/29b1dfad-b6ec-41c7-b399-708315af36db","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138773.4(SLC25A46):c.998C>T (p.Pro333Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16042259"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/be0060cc-6591-4567-899c-b487593800ea_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Functional information on this variant (loss of function) provided in Figure 2.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c098889a-0693-41c7-bfb8-659d279da657","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27543974","rdfs:label":"II.2374892","ageType":"AgeAtDeath","ageUnit":"Weeks","ageValue":4,"detectionMethod":"","firstTestingMethod":"Exome sequencing","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/be0060cc-6591-4567-899c-b487593800ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27543974","allele":{"id":"https://genegraph.clinicalgenome.org/r/218ed700-90d7-43a4-8018-1b6158269810","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138773.4(SLC25A46):c.1022T>C (p.Leu341Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16043962"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9852fb40-0df1-4668-ba57-38a4971cb244_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98ab26a6-5b42-461a-92dc-50dd340b43b4_proband_segregation","type":"FamilyCosegregation","dc:description":"Only one affected family member.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","rdfs:label":"IT","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/98ab26a6-5b42-461a-92dc-50dd340b43b4","type":"Family","rdfs:label":"IT","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/314e932c-21df-4672-a958-ac35aaed373f"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Optic atrophy, Progressive visual loss, Distal sensory impairment, Muscle weakness, Pes cavus, Steppage gait, Gait disturbance, Hyporeflexia, Hyperreflexia, Ataxia, Nystagmus, Cerebellar atrophy","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0000648","obo:HP_0002936","obo:HP_0001324","obo:HP_0001288","obo:HP_0001347","obo:HP_0000529","obo:HP_0003376","obo:HP_0001761","obo:HP_0000639","obo:HP_0001265","obo:HP_0001272","obo:HP_0001251"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/314e932c-21df-4672-a958-ac35aaed373f"}},{"id":"https://genegraph.clinicalgenome.org/r/efd94b18-b616-4cb4-9081-b40ccf788442_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","rdfs:label":"PL","estimatedLodScore":1.58,"family":{"id":"https://genegraph.clinicalgenome.org/r/efd94b18-b616-4cb4-9081-b40ccf788442","type":"Family","rdfs:label":"PL","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/776d36d5-3386-4873-bfc6-a2727ab068e0"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Optic atrophy, Progressive visual loss, Muscle weakness, Hyperreflexia, Ataxia, Cerebellar atroph","phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001347","obo:HP_0001324","obo:HP_0001251","obo:HP_0000529","obo:HP_0000648","obo:HP_0001272"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/776d36d5-3386-4873-bfc6-a2727ab068e0"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/09ff0551-646f-41ac-bef2-66fc06128b25_proband_segregation","type":"FamilyCosegregation","dc:description":"Two out of four affected family members have been tested only.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28653766","rdfs:label":"GER-F1","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/09ff0551-646f-41ac-bef2-66fc06128b25","type":"Family","rdfs:label":"GER-F1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/858f6bc1-060d-4b71-a42c-b44be68f8c2f"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Respiratory failure, Muscular hypotonia, Cerebellar atrophy, Abnormal cerebellum morphology, Muscle weakness","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001272","obo:HP_0001324","obo:HP_0001252","obo:HP_0001317","obo:HP_0002878"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/858f6bc1-060d-4b71-a42c-b44be68f8c2f"}},{"id":"https://genegraph.clinicalgenome.org/r/9876ba8e-fcfd-4961-b9e3-d115954cb95b_proband_segregation","type":"FamilyCosegregation","dc:description":"One affected family member only.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","rdfs:label":"US","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/9876ba8e-fcfd-4961-b9e3-d115954cb95b","type":"Family","rdfs:label":"US","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/098a1f18-7d22-4622-8562-fa5bba3ffa3e"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Muscular hypotonia, Generalized hypotonia, Narrow forehead, Flexion contracture, Bulbous nose, Anteverted nares, Tented upper lip vermilion, Tapered finger, Narrow palate, Respiratory failure, Inverted nipples, Optic atrophy","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0000463","obo:HP_0000414","obo:HP_0003186","obo:HP_0010804","obo:HP_0000648","obo:HP_0000341","obo:HP_0002878","obo:HP_0001371","obo:HP_0001252","obo:HP_0000189","obo:HP_0001290","obo:HP_0001182"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/098a1f18-7d22-4622-8562-fa5bba3ffa3e"}},{"id":"https://genegraph.clinicalgenome.org/r/73145326-0b5a-4a2e-9a06-1bb292be46c7_proband_segregation","type":"FamilyCosegregation","dc:description":"Less than 3 affected family members.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","rdfs:label":"UK","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/73145326-0b5a-4a2e-9a06-1bb292be46c7","type":"Family","rdfs:label":"UK","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7e5dd220-d782-493d-9f4c-0308816713c3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","rdfs:label":"UKII-2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":8,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","previousTesting":true,"previousTestingDescription":"POLG, OPA1, MFN2 single gene testing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8af2e6b0-a2fa-417b-8936-c8b453bd2d1e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168012","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a59ff9c3-59a2-49bc-81a3-e034f79b29d7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138773.4(SLC25A46):c.166dup (p.His56ProfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16044170"}},{"id":"https://genegraph.clinicalgenome.org/r/094cba61-4ab3-495f-9649-a489985cdcd2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138773.4(SLC25A46):c.746G>A (p.Gly249Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3364735"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Optic atrophy, Progressive visual loss, Hyperreflexia, Distal sensory impairment","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001347","obo:HP_0002936","obo:HP_0000648","obo:HP_0000529"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7e5dd220-d782-493d-9f4c-0308816713c3"}},{"id":"https://genegraph.clinicalgenome.org/r/ac8f876c-7a15-4440-b630-0ebe52adc858_proband_segregation","type":"FamilyCosegregation","dc:description":"Only one affected family member.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30178502","rdfs:label":"TR","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/ac8f876c-7a15-4440-b630-0ebe52adc858","type":"Family","rdfs:label":"TR","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/f01e4572-e618-4d4e-bfda-fec9256ed648"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Optic atrophy, Progressive visual loss, Muscle weakness, Hyporeflexia, Ataxia","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0001265","obo:HP_0000529","obo:HP_0001251","obo:HP_0001324","obo:HP_0000648"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/f01e4572-e618-4d4e-bfda-fec9256ed648"}},{"id":"https://genegraph.clinicalgenome.org/r/3177d6b1-0313-4b49-9b62-a1c418475edc_proband_segregation","type":"FamilyCosegregation","dc:description":"Only two family members affected.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27430653","rdfs:label":"PK","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/3177d6b1-0313-4b49-9b62-a1c418475edc","type":"Family","rdfs:label":"PK","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/068e5c6b-f11e-4a4f-81b2-ed17ca769ae6"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Optic atrophy, Progressive visual loss, Muscle weakness, Ataxia, Gait disturbance, Tremor, Scoliosis, Cerebellar atrophy, Myoclonus, Nystagmus, Dysmetria","phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001288","obo:HP_0001336","obo:HP_0001272","obo:HP_0000648","obo:HP_0002650","obo:HP_0001310","obo:HP_0001324","obo:HP_0000639","obo:HP_0001251","obo:HP_0000529","obo:HP_0001337"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/068e5c6b-f11e-4a4f-81b2-ed17ca769ae6"}},{"id":"https://genegraph.clinicalgenome.org/r/2a54d20e-47c6-499c-8c8a-f72e1e8b24bb_proband_segregation","type":"FamilyCosegregation","dc:description":"Two out of four affected family members only have been tested.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28653766","rdfs:label":"IT-F2","estimatedLodScore":1.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/2a54d20e-47c6-499c-8c8a-f72e1e8b24bb","type":"Family","rdfs:label":"IT-F2","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/6e4fb890-1e12-471f-a3df-19a4d8d24be4"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Respiratory failure, Muscular hypotonia, Cerebellar atrophy, Abnormal cerebellum morphology, Muscle weakness","phenotypeNegativeAlleleNegative":10,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0002878","obo:HP_0001252","obo:HP_0001272","obo:HP_0001317","obo:HP_0001324"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/6e4fb890-1e12-471f-a3df-19a4d8d24be4"}},{"id":"https://genegraph.clinicalgenome.org/r/74e3a9d1-056f-4d7d-aaed-2443574d1ad1_family_segregation","type":"FamilyCosegregation","dc:description":"Two affected familiy members only.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27543974","rdfs:label":"Wan 2016 Family 2","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/74e3a9d1-056f-4d7d-aaed-2443574d1ad1","type":"Family","rdfs:label":"Wan 2016 Family 2","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"}},"meetsInclusionCriteria":false,"phenotype":[{"id":"obo:HP_0001265"},{"id":"obo:HP_0001324"},{"id":"obo:HP_0002878"},{"id":"obo:HP_0001317"},{"id":"obo:HP_0000648"},{"id":"obo:HP_0001252"},{"id":"obo:HP_0001336"},{"id":"obo:HP_0001371"},{"id":"obo:HP_0001272"}],"phenotypeFreeText":"Optic atrophy, Flexion contracture, Myoclonus, Respiratory failure, Muscular hypotonia, Cerebellar atrophy, Abnormal cerebellum morphology, Muscle weakness, Hyporeflexia","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2},{"id":"https://genegraph.clinicalgenome.org/r/d4f75f07-8d61-428c-9618-63592447f748_proband_segregation","type":"FamilyCosegregation","dc:description":"Two affected family members only.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27543974","rdfs:label":"Wan 2016 Family 1","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/d4f75f07-8d61-428c-9618-63592447f748","type":"Family","rdfs:label":"Wan 2016 Family 1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/c098889a-0693-41c7-bfb8-659d279da657"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Optic atrophy, Flexion contracture, Myoclonus, Respiratory failure, Muscular hypotonia, Cerebellar atrophy, Abnormal cerebellum morphology, Muscle weakness","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000648","obo:HP_0001252","obo:HP_0001371","obo:HP_0002878","obo:HP_0001324","obo:HP_0001317","obo:HP_0001272","obo:HP_0001336"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/c098889a-0693-41c7-bfb8-659d279da657"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/8af2e6b0-a2fa-417b-8936-c8b453bd2d1e_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e5dd220-d782-493d-9f4c-0308816713c3"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":1003,"specifiedBy":"GeneValidityCriteria7","strengthScore":16.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/0SnoPHeAH1A","type":"GeneValidityProposition","disease":"obo:MONDO_0014671","gene":"hgnc:25198","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9852fb40-0df1-4668-ba57-38a4971cb244-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}